# Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer

> **NCT02128243** · PHASE2 · COMPLETED · sponsor: **AIO-Studien-gGmbH** · enrollment: 242 (actual)

## Conditions studied

- Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction
- Gastric Neoplasm
- Gastroesophageal Junction Adenocarcinoma
- Esophageal Adenocarcinoma
- Gastric Adenocarcinoma
- Esophageal Neoplasms

## Interventions

- **DRUG:** S-1 de-escalation
- **DRUG:** Chemotherapy by Investigator's choice

## Key facts

- **NCT ID:** NCT02128243
- **Lead sponsor:** AIO-Studien-gGmbH
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2020-10-08
- **Final completion:** 2020-10-08
- **Target enrollment:** 242 (ACTUAL)
- **Last updated:** 2021-03-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02128243

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02128243, "Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02128243. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*